Sponsor Pipeline

Henan Cancer Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
20
Active Trials
6
Recruiting
2
Phase 3
10
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-05 NCT07629817 Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant… Phase 3 Not Yet Recruiting
2026-06-01 NCT07618546 A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With… Not Yet Recruiting
2026-05-28 NCT07610629 Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 3
2
Phase 2
11
Phase 1/2
2
Not specified
5
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07332221 Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A… Esophageal Cancer Not Yet Recruiting
NCT07629817 Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant… Esophageal Squamous Cell Carcinoma Not Yet Recruiting
Phase 2
NCT06967103 QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer Breast Cancer Recruiting
NCT05769010 Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases Metastatic Breast Cancer Recruiting
NCT05398861 Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative… HER-2 Negative Breast Cancer Recruiting
NCT07540533 A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy… Advanced Breast Cancer Recruiting
NCT07363512 Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the… HCC - Hepatocellular Carcinoma Not Yet Recruiting
NCT06370416 the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With… Non-small Cell Lung Cancer Enrolling by Invitation
NCT04067037 Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced… Classical Hodgkin Lymphoma Active, Not Recruiting
NCT07416253 Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2… Breast Cancer Not Yet Recruiting
NCT07459608 Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Indolent… Indolent Lymphoma Not Yet Recruiting
NCT07559786 A Multicenter, Randomized, Cohort, Prospective Clinical Study of Adebrelimab… SCLC, Limited Stage Not Yet Recruiting
NCT07610629 Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for… Gastric Adenocarcinoma Not Yet Recruiting
Phase 1/2
NCT07334431 Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With… Gastric Adenocarcinoma Recruiting
NCT07559097 Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal… Leptomeningeal Metastasis From Lung Cancer Recruiting
Not specified
NCT07400575 Anlotinib in Cross-line Treatment of NSCLC and SCLC NSCLC (Advanced Non-small Cell Lung Cancer) Not Yet Recruiting
NCT07442890 A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent… Lung Cancer Not Yet Recruiting
NCT07472621 Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early… DLBCL - Diffuse Large B Cell Lymphoma Not Yet Recruiting
NCT07492407 CD20 Monoclonal Antibody-Based First-Line Therapy in Treatment-Naive Marginal Zone B-Cell… MZL Not Yet Recruiting
NCT07618546 A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With… HCC - Hepatocellular Carcinoma Not Yet Recruiting
Disease Areas
Get alerts when Henan Cancer Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free